1322 related articles for article (PubMed ID: 26468533)
1. Pan-ebolavirus and Pan-filovirus Mouse Monoclonal Antibodies: Protection against Ebola and Sudan Viruses.
Holtsberg FW; Shulenin S; Vu H; Howell KA; Patel SJ; Gunn B; Karim M; Lai JR; Frei JC; Nyakatura EK; Zeitlin L; Douglas R; Fusco ML; Froude JW; Saphire EO; Herbert AS; Wirchnianski AS; Lear-Rooney CM; Alter G; Dye JM; Glass PJ; Warfield KL; Aman MJ
J Virol; 2016 Jan; 90(1):266-78. PubMed ID: 26468533
[TBL] [Abstract][Full Text] [Related]
2. Macaque Monoclonal Antibodies Targeting Novel Conserved Epitopes within Filovirus Glycoprotein.
Keck ZY; Enterlein SG; Howell KA; Vu H; Shulenin S; Warfield KL; Froude JW; Araghi N; Douglas R; Biggins J; Lear-Rooney CM; Wirchnianski AS; Lau P; Wang Y; Herbert AS; Dye JM; Glass PJ; Holtsberg FW; Foung SK; Aman MJ
J Virol; 2016 Jan; 90(1):279-91. PubMed ID: 26468532
[TBL] [Abstract][Full Text] [Related]
3. Development of a Human Antibody Cocktail that Deploys Multiple Functions to Confer Pan-Ebolavirus Protection.
Wec AZ; Bornholdt ZA; He S; Herbert AS; Goodwin E; Wirchnianski AS; Gunn BM; Zhang Z; Zhu W; Liu G; Abelson DM; Moyer CL; Jangra RK; James RM; Bakken RR; Bohorova N; Bohorov O; Kim DH; Pauly MH; Velasco J; Bortz RH; Whaley KJ; Goldstein T; Anthony SJ; Alter G; Walker LM; Dye JM; Zeitlin L; Qiu X; Chandran K
Cell Host Microbe; 2019 Jan; 25(1):39-48.e5. PubMed ID: 30629917
[TBL] [Abstract][Full Text] [Related]
4. Novel Cross-Reactive Monoclonal Antibodies against Ebolavirus Glycoproteins Show Protection in a Murine Challenge Model.
Duehr J; Wohlbold TJ; Oestereich L; Chromikova V; Amanat F; Rajendran M; Gomez-Medina S; Mena I; tenOever BR; García-Sastre A; Basler CF; Munoz-Fontela C; Krammer F
J Virol; 2017 Aug; 91(16):. PubMed ID: 28592526
[TBL] [Abstract][Full Text] [Related]
5. Design and evaluation of bi- and trispecific antibodies targeting multiple filovirus glycoproteins.
Nyakatura EK; Zak SE; Wec AZ; Hofmann D; Shulenin S; Bakken RR; Aman MJ; Chandran K; Dye JM; Lai JR
J Biol Chem; 2018 Apr; 293(16):6201-6211. PubMed ID: 29500195
[TBL] [Abstract][Full Text] [Related]
6. Design and characterization of protective pan-ebolavirus and pan-filovirus bispecific antibodies.
Wirchnianski AS; Nyakatura EK; Herbert AS; Kuehne AI; Abbasi SA; Florez C; Storm N; McKay LGA; Dailey L; Kuang E; Abelson DM; Wec AZ; Chakraborti S; Holtsberg FW; Shulenin S; Bornholdt ZA; Aman MJ; Honko AN; Griffiths A; Dye JM; Chandran K; Lai JR
PLoS Pathog; 2024 Apr; 20(4):e1012134. PubMed ID: 38603762
[TBL] [Abstract][Full Text] [Related]
7. A Two-Antibody Pan-Ebolavirus Cocktail Confers Broad Therapeutic Protection in Ferrets and Nonhuman Primates.
Bornholdt ZA; Herbert AS; Mire CE; He S; Cross RW; Wec AZ; Abelson DM; Geisbert JB; James RM; Rahim MN; Zhu W; Borisevich V; Banadyga L; Gunn BM; Agans KN; Wirchnianski AS; Goodwin E; Tierney K; Shestowsky WS; Bohorov O; Bohorova N; Velasco J; Ailor E; Kim D; Pauly MH; Whaley KJ; Alter G; Walker LM; Chandran K; Zeitlin L; Qiu X; Geisbert TW; Dye JM
Cell Host Microbe; 2019 Jan; 25(1):49-58.e5. PubMed ID: 30629918
[TBL] [Abstract][Full Text] [Related]
8. Antibody-Mediated Protective Mechanisms Induced by a Trivalent Parainfluenza Virus-Vectored Ebolavirus Vaccine.
Kimble JB; Malherbe DC; Meyer M; Gunn BM; Karim MM; Ilinykh PA; Iampietro M; Mohamed KS; Negi S; Gilchuk P; Huang K; Wolf YI; Braun W; Crowe JE; Alter G; Bukreyev A
J Virol; 2019 Feb; 93(4):. PubMed ID: 30518655
[TBL] [Abstract][Full Text] [Related]
9. Mapping of conserved and species-specific antibody epitopes on the Ebola virus nucleoprotein.
Changula K; Yoshida R; Noyori O; Marzi A; Miyamoto H; Ishijima M; Yokoyama A; Kajihara M; Feldmann H; Mweene AS; Takada A
Virus Res; 2013 Sep; 176(1-2):83-90. PubMed ID: 23702199
[TBL] [Abstract][Full Text] [Related]
10. Chimeric Filoviruses for Identification and Characterization of Monoclonal Antibodies.
Ilinykh PA; Shen X; Flyak AI; Kuzmina N; Ksiazek TG; Crowe JE; Bukreyev A
J Virol; 2016 Apr; 90(8):3890-3901. PubMed ID: 26819310
[TBL] [Abstract][Full Text] [Related]
11. A Pan-Ebolavirus Monoclonal Antibody Cocktail Provides Protection Against Ebola and Sudan Viruses.
Liu G; He S; Chan M; Zhang Z; Schulz H; Cao W; Rahim MN; Audet J; Garnett L; Wec A; Chandran K; Qiu X; Banadyga L
J Infect Dis; 2023 Nov; 228(Suppl 7):S691-S700. PubMed ID: 37288609
[TBL] [Abstract][Full Text] [Related]
12. Generation and Characterization of Anti-Filovirus Nucleoprotein Monoclonal Antibodies.
Rahim MN; Wang M; Wang T; He S; Griffin BD; Kobasa D; Yang R; Du Z; Qiu X
Viruses; 2019 Mar; 11(3):. PubMed ID: 30875741
[TBL] [Abstract][Full Text] [Related]
13. Ferrets Infected with Bundibugyo Virus or Ebola Virus Recapitulate Important Aspects of Human Filovirus Disease.
Kozak R; He S; Kroeker A; de La Vega MA; Audet J; Wong G; Urfano C; Antonation K; Embury-Hyatt C; Kobinger GP; Qiu X
J Virol; 2016 Oct; 90(20):9209-23. PubMed ID: 27489269
[TBL] [Abstract][Full Text] [Related]
14. Early Human B Cell Response to Ebola Virus in Four U.S. Survivors of Infection.
Williamson LE; Flyak AI; Kose N; Bombardi R; Branchizio A; Reddy S; Davidson E; Doranz BJ; Fusco ML; Saphire EO; Halfmann PJ; Kawaoka Y; Piper AE; Glass PJ; Crowe JE
J Virol; 2019 Apr; 93(8):. PubMed ID: 30728263
[TBL] [Abstract][Full Text] [Related]
15. Antibodies from a Human Survivor Define Sites of Vulnerability for Broad Protection against Ebolaviruses.
Wec AZ; Herbert AS; Murin CD; Nyakatura EK; Abelson DM; Fels JM; He S; James RM; de La Vega MA; Zhu W; Bakken RR; Goodwin E; Turner HL; Jangra RK; Zeitlin L; Qiu X; Lai JR; Walker LM; Ward AB; Dye JM; Chandran K; Bornholdt ZA
Cell; 2017 May; 169(5):878-890.e15. PubMed ID: 28525755
[TBL] [Abstract][Full Text] [Related]
16. Discovery of an antibody for pan-ebolavirus therapy.
Furuyama W; Marzi A; Nanbo A; Haddock E; Maruyama J; Miyamoto H; Igarashi M; Yoshida R; Noyori O; Feldmann H; Takada A
Sci Rep; 2016 Feb; 6():20514. PubMed ID: 26861827
[TBL] [Abstract][Full Text] [Related]
17. Multifunctional Pan-ebolavirus Antibody Recognizes a Site of Broad Vulnerability on the Ebolavirus Glycoprotein.
Gilchuk P; Kuzmina N; Ilinykh PA; Huang K; Gunn BM; Bryan A; Davidson E; Doranz BJ; Turner HL; Fusco ML; Bramble MS; Hoff NA; Binshtein E; Kose N; Flyak AI; Flinko R; Orlandi C; Carnahan R; Parrish EH; Sevy AM; Bombardi RG; Singh PK; Mukadi P; Muyembe-Tamfum JJ; Ohi MD; Saphire EO; Lewis GK; Alter G; Ward AB; Rimoin AW; Bukreyev A; Crowe JE
Immunity; 2018 Aug; 49(2):363-374.e10. PubMed ID: 30029854
[TBL] [Abstract][Full Text] [Related]
18. Bispecific Antibody Affords Complete Post-Exposure Protection of Mice from Both Ebola (Zaire) and Sudan Viruses.
Frei JC; Nyakatura EK; Zak SE; Bakken RR; Chandran K; Dye JM; Lai JR
Sci Rep; 2016 Jan; 6():19193. PubMed ID: 26758505
[TBL] [Abstract][Full Text] [Related]
19. Distinct Immunogenicity and Efficacy of Poxvirus-Based Vaccine Candidates against Ebola Virus Expressing GP and VP40 Proteins.
Lázaro-Frías A; Gómez-Medina S; Sánchez-Sampedro L; Ljungberg K; Ustav M; Liljeström P; Muñoz-Fontela C; Esteban M; García-Arriaza J
J Virol; 2018 Jun; 92(11):. PubMed ID: 29514907
[No Abstract] [Full Text] [Related]
20. Antibody Treatment of Ebola and Sudan Virus Infection via a Uniquely Exposed Epitope within the Glycoprotein Receptor-Binding Site.
Howell KA; Qiu X; Brannan JM; Bryan C; Davidson E; Holtsberg FW; Wec AZ; Shulenin S; Biggins JE; Douglas R; Enterlein SG; Turner HL; Pallesen J; Murin CD; He S; Kroeker A; Vu H; Herbert AS; Fusco ML; Nyakatura EK; Lai JR; Keck ZY; Foung SKH; Saphire EO; Zeitlin L; Ward AB; Chandran K; Doranz BJ; Kobinger GP; Dye JM; Aman MJ
Cell Rep; 2016 May; 15(7):1514-1526. PubMed ID: 27160900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
